DEADLINE: Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – SBTX
SAN DIEGO, Nov. 13, 2021 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of: (1) Silverback Therapeutics Inc. (NASDAQ: SBTX) common stock pursuant and/or traceable to the offering documents issued in connection with…
